AQS.V - Aequus Pharmaceuticals Inc.

TSXV - TSXV Delayed Price. Currency in CAD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue2018-12-312017-12-312016-12-312015-12-31
Total Revenue1,410.241,139.424701.633-
Cost of Revenue----
Gross Profit1,410.241,139.424701.633-
Operating Expenses
Research Development526.9351,414.7061,127.782,144.488
Selling General and Administrative3,691.3343,727.1764,437.4362,910.662
Non Recurring----
Others----
Total Operating Expenses4,218.2695,141.8825,565.2165,055.15
Operating Income or Loss-2,808.029-4,002.458-4,863.583-5,055.15
Income from Continuing Operations
Total Other Income/Expenses Net4.289120.0310.80743.745
Earnings Before Interest and Taxes-2,808.029-4,002.458-4,863.583-5,055.15
Interest Expense----
Income Before Tax-2,803.74-3,882.427-4,862.776-5,011.405
Income Tax Expense---50.721-
Minority Interest----
Net Income From Continuing Ops-2,803.74-3,882.427-4,812.055-5,011.405
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-2,803.74-3,882.427-4,812.055-5,011.405
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-2,803.74-3,882.427-4,812.055-5,011.405